Catalyst Wire Dossier Catalyst Wire Dossier

ZT003

· Beijing QL Biopharmaceutical Co.,Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZT003, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers [Phase 1]

See pricing